Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer

Our aim was to study the feasibility of an intensified intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) schedule with the aim to escalate dose intensity (DI). Twenty-three premenopausal breast cancer patients received 6 cycles of adjuvant CMF intravenously on days 1 and 8 every 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Bos, A M E, Graaf, H de, Vries, E G E de, Piersma, H, Willemse, P H B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363251/
https://www.ncbi.nlm.nih.gov/pubmed/10864198
http://dx.doi.org/10.1054/bjoc.2000.1242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363251/
https://www.ncbi.nlm.nih.gov/pubmed/10864198
http://dx.doi.org/10.1054/bjoc.2000.1242

Ejemplares similares